Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment.

Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment.

Item
http://www.wikidata.org/entity/Q36695952
Preclinical development of monoclonal antibodies: considerations for the use of non-human primatesZebrafish: A complete animal model to enumerate the nanoparticle toxicityA novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapyEfficient Generation of Bispecific Murine Antibodies for Pre-Clinical Investigations in Syngeneic Rodent ModelsAnimal model of naturally occurring bladder cancer: characterization of four new canine transitional cell carcinoma cell lines.Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge ModelNovel genetically-humanized mouse model established to evaluate efficacy of therapeutic agents to human interleukin-6 receptor.Effect of alemtuzumab on intestinal intraepithelial lymphocytes and intestinal barrier function in cynomolgus modelImpact of treatment response metrics on photodynamic therapy planning and outcomes in a three-dimensional model of ovarian cancer.The response of intestinal stem cells and epithelium after alemtuzumab administration.Therapeutic antibodies in ophthalmology: old is new again.Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis.Developing Exposure/Response Models for Anticancer Drug Treatment: Special ConsiderationsDrug Development of Therapeutic Monoclonal Antibodies.Trastuzumab triggers phagocytic killing of high HER2 cancer cells in vitro and in vivo by interaction with Fcγ receptors on macrophages.Chimeric, divalent and tetravalent anti-CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B-cell lymphoma and pre-B acute lymphoblastic leukemia cell lines.Affinity of human IgG subclasses to mouse Fc gamma receptors.
P2860

Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment.

Item
http://www.wikidata.org/entity/Q36695952
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Relevance, advantages and limi ...... tibodies for cancer treatment.
@ast
Relevance, advantages and limi ...... tibodies for cancer treatment.
@en
type
label
Relevance, advantages and limi ...... tibodies for cancer treatment.
@ast
Relevance, advantages and limi ...... tibodies for cancer treatment.
@en
prefLabel
Relevance, advantages and limi ...... tibodies for cancer treatment.
@ast
Relevance, advantages and limi ...... tibodies for cancer treatment.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Relevance, advantages and limi ...... ntibodies for cancer treatment
@en
P2093
P304
P31
P356
10.1016/J.CRITREVONC.2006.11.010
P433
P478
P50
P577
P5875
P698